User profiles for Titus Abiola Olukitibi
 | Titus OlukitibiPhd Candidate, University of Manitoba Verified email at myumanitoba.ca Cited by 141 |
[HTML][HTML] Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry
Until now, antiviral therapeutic agents are still urgently required for treatment or prevention
of SARS-coronavirus 2 (SCoV-2) virus infection. In this study, we established a sensitive …
of SARS-coronavirus 2 (SCoV-2) virus infection. In this study, we established a sensitive …
[PDF][PDF] SARS-CoV-2 Delta spike protein enhances the viral fusogenicity and inflammatory cytokine production
The Delta variant had spread globally in 2021 and caused more serious disease than the
original virus and Omicron variant. In this study, we investigated several virological features of …
original virus and Omicron variant. In this study, we investigated several virological features of …
Development and evaluation of an Ebola virus glycoprotein mucin-like domain replacement system as a new dendritic cell-targeting vaccine approach against HIV-1
Z Ao, L Wang, H Azizi, TA Olukitibi, G Kobinger… - Journal of …, 2021 - Am Soc Microbiol
The development of efficient vaccine approaches against HIV infection remains challenging
in the vaccine field. Here, we developed an Ebola virus envelope glycoprotein (EboGP)-…
in the vaccine field. Here, we developed an Ebola virus envelope glycoprotein (EboGP)-…
[HTML][HTML] Dendritic cells/macrophages-targeting feature of Ebola glycoprotein and its potential as immunological facilitator for antiviral vaccine approach
In the prevention of epidemic and pandemic viral infection, the use of the antiviral vaccine
has been the most successful biotechnological and biomedical approach. In recent times, …
has been the most successful biotechnological and biomedical approach. In recent times, …
[HTML][HTML] Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
TA Olukitibi, Z Ao, H Azizi, M Mahmoudi… - Frontiers in …, 2022 - frontiersin.org
A universal influenza vaccine is required for broad protection against influenza infection.
Here, we revealed the efficacy of novel influenza vaccine candidates based on Ebola …
Here, we revealed the efficacy of novel influenza vaccine candidates based on Ebola …
Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus
COVID-19 and influenza are both highly contagious respiratory diseases with a wide range
of severe symptoms and cause great disease burdens globally. It has become very urgent …
of severe symptoms and cause great disease burdens globally. It has become very urgent …
Development and characterization of influenza M2 ectodomain and/or HA stalk-based DC-targeting vaccines for different influenza infections
TA Olukitibi, Z Ao, H Azizi, M Mahmoudi, K Coombs… - BioRxiv, 2021 - biorxiv.org
A universal influenza vaccine is required for broad protection against influenza infection.
Here, we revealed the efficacy of novel influenza vaccine candidates based on Ebola …
Here, we revealed the efficacy of novel influenza vaccine candidates based on Ebola …
Prunella vulgaris extract and suramin block SARS-coronavirus 2 virus Spike protein D614 and G614 variants mediated receptor association and virus entry in cell …
Z Ao, M Chan, MJ Ouyang, OT Abiola, M Mahmoudi… - BioRxiv, 2020 - biorxiv.org
Until now, no approved effective vaccine and antiviral therapeutic are available for treatment
or prevention of SARS-coronavirus 2 (SCoV-2) virus infection. In this study, we established …
or prevention of SARS-coronavirus 2 (SCoV-2) virus infection. In this study, we established …
Prunella vulgaris Extract Blocks SARS- Coronavirus 2 Virus Spike Protein D614 and G614 Variants Mediated Receptor Binding and Virus Entry
Z Ao, M Chan, MJ Ouyang, OT Abiola… - Extract Blocks SARS …, 2020 - papers.ssrn.com
Until now, there is no approved effective vaccine, and antiviral therapeutic agents available
for treatment or prevention of SARS-coronavirus 2 (SCoV-2) virus infection. In this study, we …
for treatment or prevention of SARS-coronavirus 2 (SCoV-2) virus infection. In this study, we …
SARS-CoV-2 Delta Spike Protein Enhances the Viral Fusogenicity and Inflammatory Cytokine Production (preprint)
The Delta variant is now the most dominant and virulent SARS-CoV-2 variant of concern (VOC).
In this study, we investigated several virological features of Delta spike protein (SPDelta)…
In this study, we investigated several virological features of Delta spike protein (SPDelta)…